FDA clears first gene-altering therapy — ‘a living drug’ — for childhood leukemia

fda-approves-first-of-its-kind-living-drug-for-childhood-leukemia

The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients’ genetically altered immune cells to fight the disease.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Gene Therapy Featured / FDA clears first gene-altering therapy — ‘a living drug’ — for childhood leukemia